Tabatabaei-Panah P, Moravvej H, Hajihasani M, Mousavi M, Ludwig R, Akbarzadeh R
Immun Inflamm Dis. 2021; 10(2):209-217.
PMID: 34752683
PMC: 8767509.
DOI: 10.1002/iid3.564.
Kochetova O, Avzaletdinova D, Morugova T, Mustafina O
Mol Biol Rep. 2018; 46(1):887-896.
PMID: 30536157
DOI: 10.1007/s11033-018-4544-6.
Wang Y, Huang S, Wu X, Wang Y, Jiang D
J Neural Transm (Vienna). 2018; 125(12):1781-1786.
PMID: 30284076
DOI: 10.1007/s00702-018-1936-7.
Sharma N, Sharma K, Singh R, Sharma S, Anand A
PLoS One. 2018; 13(4):e0193423.
PMID: 29664944
PMC: 5903598.
DOI: 10.1371/journal.pone.0193423.
Hsieh Y, Hsieh F, Chen Y, Hu C, Jeng J, Tang S
J Biomed Sci. 2017; 24(1):25.
PMID: 28351426
PMC: 5371181.
DOI: 10.1186/s12929-017-0332-1.
Association of interleukin-6 genetic polymorphisms with risk of OSCC in Indian population.
Singh P, Chandra G, Bogra J, Gupta R, Kumar V, Jain A
Meta Gene. 2015; 4:142-51.
PMID: 26005639
PMC: 4436510.
DOI: 10.1016/j.mgene.2015.03.002.
The protective effect of MCP-1 -2518 A>G promoter polymorphism in Turkish chronic renal failure patients requiring long-term hemodialysis.
Bagci B, Bagci G, Candan F, Ozdemir O, Sezgin I
Int Urol Nephrol. 2015; 47(3):551-6.
PMID: 25655256
DOI: 10.1007/s11255-015-0922-3.
The associations between the MCP-1 -2518 A/G polymorphism and ischemic heart disease and ischemic stroke: a meta-analysis of 28 research studies involving 21,524 individuals.
Cai G, Zhang B, Weng W, Shi G, Huang Z
Mol Biol Rep. 2014; 42(5):997-1012.
PMID: 25413568
DOI: 10.1007/s11033-014-3836-8.
The role of infection in Kawasaki syndrome.
Principi N, Rigante D, Esposito S
J Infect. 2013; 67(1):1-10.
PMID: 23603251
PMC: 7132405.
DOI: 10.1016/j.jinf.2013.04.004.
Monocyte chemoattractant protein-1 promoter polymorphism and plasma levels in alzheimer's disease.
Porcellini E, Ianni M, Carbone I, Franceschi M, Licastro F
Immun Ageing. 2013; 10(1):6.
PMID: 23432970
PMC: 3610278.
DOI: 10.1186/1742-4933-10-6.
Genetic polymorphisms in Kawasaki disease.
Kuo H, Chang W
Acta Pharmacol Sin. 2011; 32(10):1193-8.
PMID: 21892198
PMC: 4010074.
DOI: 10.1038/aps.2011.93.
Interleukin-6 (-636 c/g) gene polymorphism in korean children with kawasaki disease.
Ahn H, Park I, Hong S, Hong Y
Korean Circ J. 2011; 41(6):321-6.
PMID: 21779285
PMC: 3132694.
DOI: 10.4070/kcj.2011.41.6.321.
Association of CCR2-CCR5 haplotypes and CCL3L1 copy number with Kawasaki Disease, coronary artery lesions, and IVIG responses in Japanese children.
Mamtani M, Matsubara T, Shimizu C, Furukawa S, Akagi T, Onouchi Y
PLoS One. 2010; 5(7):e11458.
PMID: 20628649
PMC: 2898815.
DOI: 10.1371/journal.pone.0011458.
Circulating levels of 8 cytokines and marine n-3 fatty acids and indices of obesity in Japanese, white, and Japanese American middle-aged men.
Sekikawa A, Kadowaki T, Curb J, Evans R, Maegawa H, Abbott R
J Interferon Cytokine Res. 2010; 30(7):541-8.
PMID: 20626294
PMC: 2950061.
DOI: 10.1089/jir.2009.0114.
Combined effect of inflammatory gene polymorphisms and the risk of ischemic stroke in a prospective cohort of subjects with type 2 diabetes: a Go-DARTS study.
Palmer C, Kimber C, Doney A, Proia A, Morris A, Gaetani E
Diabetes. 2010; 59(11):2945-8.
PMID: 20622166
PMC: 2963555.
DOI: 10.2337/db09-1690.
Monocyte chemoattractant protein-1-2518 G/A polymorphism, plasma levels, and premature stable coronary artery disease.
Zhong C, Luzhan Z, Genshan M, Jiahong W, Xiaoli Z, Qi Q
Mol Biol Rep. 2009; 37(1):7-12.
PMID: 19247801
DOI: 10.1007/s11033-009-9479-5.
Association of polymorphisms in monocyte chemoattractant protein-1 promoter with diabetic kidney failure in Korean patients with type 2 diabetes mellitus.
Moon J, Jeong L, Lee S, Jeong K, Lee T, Ihm C
J Korean Med Sci. 2007; 22(5):810-4.
PMID: 17982227
PMC: 2693845.
DOI: 10.3346/jkms.2007.22.5.810.
Polymorphisms of the MCP-1 and HSP70-2 genes in Korean patients with alcoholic chronic pancreatitis.
Lee S, Ryu J, Jeong J, Lee K, Woo S, Park J
Dig Dis Sci. 2007; 53(6):1721-7.
PMID: 17940904
DOI: 10.1007/s10620-007-0049-1.
The chemokine network. II. On how polymorphisms and alternative splicing increase the number of molecular species and configure intricate patterns of disease susceptibility.
Colobran R, Pujol-Borrell R, Armengol M, Juan M
Clin Exp Immunol. 2007; 150(1):1-12.
PMID: 17848170
PMC: 2219280.
DOI: 10.1111/j.1365-2249.2007.03489.x.
Kawasaki disease.
Kim D
Yonsei Med J. 2006; 47(6):759-72.
PMID: 17191303
PMC: 2687814.
DOI: 10.3349/ymj.2006.47.6.759.
